SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2708Bristol-Myers boosts ImClone bid to $62 per share NEW YORK (AP) — A rebuffed Brsim1-9/22/2008
2707Excellent choice for my 2008 charity portfolio, that NTEC was. You can't wiBiotech Jim-9/19/2008
2706<b>Drugmakers Shift Emphasis to Biotech M&A</b> <i>[This DewDiligence_on_SI-9/19/2008
2705thanks...fredfred hayes-9/18/2008
2704<i>Or did I misread this?</i> I think you did. My read is that 0.27DewDiligence_on_SI-9/18/2008
2703NTEC: "Certain intellectual property rights...retained by Neose for future fred hayes-9/18/2008
2702Protherics agrees to BTG takeover LONDON (ShareCast) - Life sciences company BTGnigel bates-9/18/2008
2701NTEC Accepts $43M Liquidation Deal: siliconinvestor.comDewDiligence_on_SI-9/18/2008
2700<<Shares of ImClone fell in Tuesday trading, shedding about $3.33, or 5%, Miljenko Zuanic-9/17/2008
26997:30AM Biovail acquires Prestwick Pharmaceuticals for $100 mln (BVF) 10.22 : Co Ian@SI-9/17/2008
2698September 17, 2008, 9:18 am Small Swedish Pharma Could Be Buyout Target for PfizIan@SI-9/17/2008
2697<i>Shares of ImClone fell in Tuesday trading, shedding about $3.33, or 5%,DewDiligence_on_SI-9/17/2008
2696Bayer buys German biotech Direvo for 210 mln eur FRANKFURT, Sept 16 (Reuters) - nigel bates-9/17/2008
2695Bristol-Myers Could Drop ImClone Offer Article SEPTEMBER 17, 2008 <i>MiDoc Bones-9/17/2008
2694<i>When do you think the $70 bidder will be disclosed?</i> At the eDewDiligence_on_SI-9/13/2008
2693Talecris (remnant of Bayer/Cutter biologics business), recently pre-munched by Cscaram(o)uche-9/13/2008
2692You're being too kind to BP.rkrw-9/13/2008
2691I wasn't suggesting that BP are all idiots - just that they are far from immnigel bates-9/13/2008
2690When do you think the $70 bidder will be disclosed?rkrw-9/13/2008
2689Seems over the top. But otoh. There were rumors last week when the pfizer/bayer rkrw-9/13/2008
2688[OT] FiveThirtyEight.com now has ND at 95/5 for McCain. You previously posted tDewDiligence_on_SI-9/13/2008
2687Since when did everything that BP does make sense ? :)nigel bates-9/13/2008
2686<i>>Can't say I think it makes any sense for someone to acquire IMCDewDiligence_on_SI-9/13/2008
2685<i>Safer Erbitux means less potent drug, regardless is it for cancer or asDewDiligence_on_SI-9/13/2008
2684<<As far as I can tell, IMC-11F8 will not be better than Erbitux, but rathMiljenko Zuanic-9/12/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News